Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Indiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Indiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Indiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Raja Devanathan (NPI 1871587220)

Field	Value
Entity Type	Individual
Organization	Raja Devanathan
Address	7875 Grand Blvd
City	Hobart
State	IN
ZIP	46342
Taxonomy	Pulmonary Disease Physician
NPI Enumerated	August 31, 2005

Payer Source	Total Paid
Medicare	$3M
Medicaid	$0

Key Findings

RAJA DEVANATHAN is a Pulmonary Disease Physician with an NPI enumerated on 2005-08-31 (~21 years ago) and shows $3M in lifetime Medicare revenue; the provider has no Medicaid billing on file, so the practice is effectively single-payer in the dataset and heavily reliant on Medicare volume. The absence of Medicaid billing (none (no Medicaid billing on file)) suggests limited direct participation in state Medicaid programs or no Medicaid-billed services captured in this data extract.

Revenue is highly concentrated in a small set of biologic drug codes: the precomputed top three Medicare codes (J2182, J0517, J2357) account for 75.1% of this provider's total Medicare revenue. Those three line items are J2182 $993.6K revenue (33.0%), J0517 $649.4K revenue (21.6%), and J2357 $616.8K revenue (20.5%), which together dominate the provider’s Medicare receipts.

The code mix points to an outpatient, injection-focused specialty operation: J2182 (mepolizumab), J0517 (benralizumab), J2357 (omalizumab) and a substantial J2356 (tezepelumab-ekko) line ($443.9K revenue, 14.7%) indicate routine administration of high-volume respiratory biologics for severe asthma and related conditions. Complementary pulmonary testing codes such as 94729, 94726 and 94060 appear in the top-25, supporting a clinical model that combines biologic injections with diagnostic pulmonary function testing.

For competitive standing, this provider is a national outlier on several biologic codes: J2182 ranks #1 of 187 providers nationally (100th percentile; extreme outlier), J0517 ranks #4 of 200 (98th percentile; extreme outlier), and J2357 ranks #17 of 581 (97th percentile; notably above typical national volume). Those placements indicate the provider is a dominant, high-volume participant for these specific injectable therapies compared with national peers.

Beyond biologics, there are other atypical volume signals in inpatient and procedural billing: 99232 appears with 1.4K claims and $81.9K revenue and ranks #2625 of 177383 providers nationally (99th percentile; extreme outlier), while 96401 has 1.2K claims and $62K revenue and ranks #39 of 3868 providers nationally (99th percentile; extreme outlier). These entries suggest the practice also performs substantial in-person administration of complex therapies and participates in hospital/observation care, not solely office-based visits.

The practice bills a range of chronic care and remote-monitoring codes (99457, 99490, 99439) and routine E/M codes (99212, 99213, 99205), indicating mixed ambulatory management of chronic respiratory disease alongside the biologic administration workflow. Some of these E/M codes are high-volume relative to peers (eg, 99212: 856 claims, $32.5K revenue, ranks #356 of 99011 providers nationally (100th percentile; extreme outlier)), while others like 99213 show typical volumes (276 claims, $17.1K revenue, ranks #66798 of 457151 providers nationally (85th percentile; typical, unremarkable)).

From a payer-management perspective, the practice’s heavy dependence on high-revenue biologic injections concentrates financial risk: policy, reimbursement, or supplier changes affecting J2182, J0517, J2357 or J2356 could materially move overall revenue given these codes’ large shares. Conversely, the provider’s top national rankings on key biologic codes (including extreme outlier status) may give it leverage or visibility in network negotiations specific to biologic administration services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

35 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2182	Injection, mepolizumab, 1 mg	43,200	$20	$993.6K
J0517	Injection, benralizumab, 1 mg	4,920	$130	$649.4K
J2357	Injection, omalizumab, 5 mg	20,560	$30	$616.8K
J2356	Injection, tezepelumab-ekko, 1 mg	31,710	$10	$443.9K
99232	The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or…	1,410	$60	$81.9K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	1,190	$50	$62K
99212	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,…	860	$40	$32.5K
99222	The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or…	280	$90	$26.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	280	$60	$17.1K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	90	$140	$13.3K

Showing 1–10 of 35

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 35 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Indiana Distribution

Raja Devanathan — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Indiana

Full comparison — all codes billed, vs. state median

35 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2182	1	10	43,200	$20	$1M
J0517	1	10	4,920	$130	$651.5K
J2356	1	10	31,710	$10	$455.3K
J2357	1	10	5,810	$30	$227K
99233	1,509	2,720	80	$90	$13.4K
99232	63	3,970	90	$60	$11.8K
99490	293	510	120	$40	$10.4K
99291	913	1,390	40	$160	$10.3K
99223	1,426	3,080	40	$120	$8.2K
96401	1	60	100	$50	$8K

Showing 1–10 of 35

Related Providers

Other providers that share a Tax Identification Number (TIN) with Raja Devanathan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Methodist Hospitals, Inc	IN	General Acute Care Hospital	$0	$75.6M
Community Care Network Inc	IN	Family Medicine Physician	$0	$33.9M
Franciscan Health Crown Point	IN	General Acute Care Hospital	$0	$11.4M
The Methodist Hospitals, Inc	IN	Internal Medicine Physician	$0	$10.9M
Mohamad Kassar	IN	Hematology & Oncology Physician	$4.7M	$0
Ramon Lee	IL	Retina Specialist (Ophthalmology) Physician	$4M	$8.5K
Sohail Hasan	IL	Retina Specialist (Ophthalmology) Physician	$3.4M	$34.2K
Neel Shah	IN	Hematology & Oncology Physician	$3.2M	$0
Michael Tallarico	IN	Medical Oncology Physician	$2.7M	$0
Kourous Rezaei	IL	Retina Specialist (Ophthalmology) Physician	$2.7M	$0

Nearby Providers

Other providers in the same ZIP code as Raja Devanathan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
St Mary Medical Center Inc	IN	General Acute Care Hospital	$0	$23.5M
Epmg Of Indiana, PC	IN	Emergency Medical Services (Emergency Medicine) Physician	$0	$3.1M
Cep America LLC	IN	Emergency Medicine Physician	$0	$2.8M
City Of Hobart	IN	Ambulance	$266.5K	$1.2M
Guneesh Saluja	IN	Emergency Medicine Physician	$119K	$494.6K
Zlatan Stepanovic	IN	Cardiovascular Disease Physician	$365.3K	$0
William Frey	IN	Optometrist	$13.3K	$330.3K
Anne Meier	IN	Hematology & Oncology Physician	$326.1K	$0
Amer Sidani	IN	Hematology & Oncology Physician	$318.2K	$0
Eduardo Fletes	IN	Internal Medicine Physician	$315.1K	$0

Raja Devanathan — Billing Profile & Reimbursement Data

Sign up for Raja Devanathan — Billing Profile & Reimbursement Data policy alerts

Raja Devanathan — Billing Profile & Reimbursement Data

Sign up for Raja Devanathan — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References